|
GALNT3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.206200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.459600E-01 |
| Normal-vs-Stage2 |
1.836350E-04 |
| Normal-vs-Stage3 |
5.517800E-01 |
| Normal-vs-Stage4 |
3.066800E-01 |
| Stage1-vs-Stage2 |
1.438830E-03 |
| Stage1-vs-Stage3 |
6.454800E-01 |
| Stage1-vs-Stage4 |
3.059900E-02 |
| Stage2-vs-Stage3 |
2.044300E-03 |
| Stage2-vs-Stage4 |
1.192190E-04 |
| Stage3-vs-Stage4 |
1.256420E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.501400E-01 |
| Normal-vs-AfricanAmerican |
2.599200E-01 |
| Normal-vs-Asian |
3.105200E-01 |
| Caucasian-vs-AfricanAmerican |
1.603430E-01 |
| Caucasian-vs-Asian |
5.188000E-01 |
| AfricanAmerican-vs-Asian |
9.850000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.343630E-01 |
| Normal-vs-Female |
3.252800E-01 |
| Male-vs-Female |
3.963400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.401000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.747160E-01 |
| Normal-vs-Age(61-80Yrs) |
2.855600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.480200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.242200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.462200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.482400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.667400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.357800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.730200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.123450E-03 |
| Classical-VS-Follicular |
5.71339999977383E-07 |
| Classical-VS-Other |
7.055400E-01 |
| Classical-VS-Normal |
7.024600E-01 |
| Tall-VS-Follicular |
2.56840004819736E-09 |
| Tall-VS-Other |
2.375000E-01 |
| Tall-VS-Normal |
4.441600E-03 |
| Follicular-VS-Other |
3.711600E-02 |
| Follicular-VS-Normal |
4.38890000000747E-05 |
| Other-VS-Normal |
7.737400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.188480E-02 |
| Normal-vs-N1 |
5.996000E-01 |
| N0-vs-N1 |
1.296810E-01 |
|
|
